118 related articles for article (PubMed ID: 37558457)
1. External Validation of the HELT-E
Yamauchi T; Okumura Y; Nagashima K; Watanabe R; Saito Y; Yokoyama K; Matsumoto N; Miyauchi K; Miyazaki S; Hayashi H; Matsue Y; Nishizaki Y; Nojiri S; Minamino T; Daida H
Circ J; 2023 Nov; 87(12):1777-1787. PubMed ID: 37558457
[TBL] [Abstract][Full Text] [Related]
2. A Novel Risk Stratification System for Ischemic Stroke in Japanese Patients With Non-Valvular Atrial Fibrillation.
Okumura K; Tomita H; Nakai M; Kodani E; Akao M; Suzuki S; Hayashi K; Sawano M; Goya M; Yamashita T; Fukuda K; Ogawa H; Tsuda T; Isobe M; Toyoda K; Miyamoto Y; Miyata H; Okamura T; Sasahara Y;
Circ J; 2021 Jul; 85(8):1254-1262. PubMed ID: 33762526
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry.
Iso K; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Hayashi H; Iwasaki YK; Shimizu W; Nakajima I; Harada T; Koyama J; Okumura K; Tokuda M; Yamane T; Tanimoto K; Momiyama Y; Nonoguchi N; Soejima K; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Yazaki Y; Satomi K; Watari Y; Okumura Y;
Heart Vessels; 2021 Apr; 36(4):549-560. PubMed ID: 33236221
[TBL] [Abstract][Full Text] [Related]
4. Registry of Japanese patients with atrial fibrillation focused on anticoagulant therapy in the new era: The RAFFINE registry study design and baseline characteristics.
Miyazaki S; Miyauchi K; Hayashi H; Tanaka R; Nojiri S; Miyazaki T; Sumiyoshi M; Suwa S; Nakazato Y; Urabe T; Hattori N; Daida H
J Cardiol; 2018 Jun; 71(6):590-596. PubMed ID: 29502944
[TBL] [Abstract][Full Text] [Related]
5. Validation of Risk Scoring System Excluding Female Sex From CHA2DS2-VASc in Japanese Patients With Nonvalvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry.
Tomita H; Okumura K; Inoue H; Atarashi H; Yamashita T; Origasa H; Tsushima E;
Circ J; 2015; 79(8):1719-26. PubMed ID: 25971525
[TBL] [Abstract][Full Text] [Related]
6. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
7. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
[TBL] [Abstract][Full Text] [Related]
8. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
[TBL] [Abstract][Full Text] [Related]
9. ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry.
Wang Y; Jiang C; He L; Du X; Guo X; Tang R; Sang C; Long D; Dong J; Hijazi Z; Lip GYH; Ma C
Chin Med J (Engl); 2023 Oct; 136(20):2451-2458. PubMed ID: 37858319
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors Associated With Ischemic Stroke in Japanese Patients With Nonvalvular Atrial Fibrillation.
Okumura K; Tomita H; Nakai M; Kodani E; Akao M; Suzuki S; Hayashi K; Sawano M; Goya M; Yamashita T; Fukuda K; Ogawa H; Tsuda T; Isobe M; Toyoda K; Miyamoto Y; Miyata H; Okamura T; Sasahara Y;
JAMA Netw Open; 2020 Apr; 3(4):e202881. PubMed ID: 32293685
[TBL] [Abstract][Full Text] [Related]
11. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
12. CHA
Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
[TBL] [Abstract][Full Text] [Related]
13. CHA
Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
15. Choosing Between HELT-E
Suzuki S
Circ J; 2023 Nov; 87(12):1788-1789. PubMed ID: 37648455
[No Abstract] [Full Text] [Related]
16. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
Chao TF; Lip GYH; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
J Am Coll Cardiol; 2018 Jan; 71(2):122-132. PubMed ID: 29325634
[TBL] [Abstract][Full Text] [Related]
17. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
18. The value of the European society of cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationwide cohort study.
Lip GYH; Nielsen PB; Skjøth F; Lane DA; Rasmussen LH; Larsen TB
Chest; 2014 Nov; 146(5):1337-1346. PubMed ID: 25086251
[TBL] [Abstract][Full Text] [Related]
19. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M
Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957
[TBL] [Abstract][Full Text] [Related]
20. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
